ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,498Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 1155

$449K Total Retail Price of All Prescriptions

Rank: 70 out of 1155

392 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 392 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

27% of this provider’s 392 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 7,551 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
HYDROCODONE-ACETAMINOPHEN 460 390 S3 1 4
LISINOPRIL 366 314 2 1
LEVOTHYROXINE SODIUM 323 304 3 2
SIMVASTATIN 289 286 4 3
ATENOLOL 275 265 5 10
FUROSEMIDE 225 206 6 8
OMEPRAZOLE 186 177 7 5
POTASSIUM CHLORIDE 163 150 8 16
WARFARIN SODIUM 140 126 9 11
MELOXICAM 136 125 10 52
METOPROLOL SUCCINATE 134 120 11 17
AMLODIPINE BESYLATE 132 116 12 6
ATORVASTATIN CALCIUM 130 130 13 12
ZOLPIDEM TARTRATE 123 110 14 21
METOPROLOL TARTRATE 117 112 15 14
MORPHINE SULFATE ER 105 65 S2 16 36
DIGOXIN 103 103 17 54
TRAZODONE HCL 99 63 18 22
PRAVASTATIN SODIUM 98 94 19 20
SYNTHROID 97 97 20 91
TAMSULOSIN HCL 97 85 20 27
ALLOPURINOL 95 92 22 29
GABAPENTIN 95 91 22 15
HYDROCHLOROTHIAZIDE 94 85 24 9
LOSARTAN-HYDROCHLOROTHIAZIDE 91 91 25 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 74 26 26
METFORMIN HCL ER 74 60 26 53
GLIMEPIRIDE 72 72 28 43
LOSARTAN POTASSIUM 72 72 28 18
METFORMIN HCL 71 71 30 7
FENTANYL 62 58 S2 31 64
CITALOPRAM HBR 60 49 32 19
SERTRALINE HCL 58 46 33 24
SPIRONOLACTONE 52 52 34 55
LOVASTATIN 51 51 35 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 12, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.